Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,850
Sort by:
Global Cancer Vaccine Partnering Terms and Agreements 2010-2021
US$ 3,495.00
... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...
May 2021
250 pages
Global Cancer Diagnostics Partnering Terms and Agreements 2014-2021
US$ 3,495.00
... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...
May 2021
550 pages
Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals)- Global Forecasts to 2026
US$ 4,950.00
... growth of the cancer diagnostics market. The instrument-based cancer diagnostics segment accounted for the largest share of the global the cancer diagnostics market, by technology, while breast cancer accounted for the largest share of the cancer diagnostics applications market ...
April 2021
282 pages
Immuno Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics) - Global Forecast to 2026
US$ 4,950.00
... of the immuno-oncology assays market.” The immuno-oncology assays market is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The immuno-oncology assays market is driven ...
April 2021
209 pages
Melanoma - Global Drug Forecast and Market Analysis to 2029
US$ 10,995.00
Melanoma - Global Drug Forecast and Market Analysis to 2029 SUMMARY Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and can dev...
April 2021
131 pages
Small Cell Lung Cancer - Epidemiology Forecast to 2029
US$ 3,995.00
Small Cell Lung Cancer - Epidemiology Forecast to 2029 SUMMARY SCLC accounts for 15% of all lung cancers. SCLC is an aggressive form of lung cancer where approximately 60-70% of patients already have...
April 2021
40 pages
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
This report can be delivered to the clients within 72 Business Hours Breast Cancer Diagnostics Market Growth & Trends The global breast cancer diagnostics market size is expected to reach USD 6.8 bi...
April 2021
118 pages
Angiosarcoma - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Angiosarcoma Global Clinical Trials Review, H1, 2017 SUMMARY GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H1, 2017' provides an overview of Angiosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Angiosarcoma ...
March 2021
153 pages
Vaginal Cancer - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Vaginal Cancer - Global Clinical Trials Review, H1, 2021 SUMMARY GlobalData's clinical trial report, “Vaginal Cancer - Global Clinical Trials Review, H1, 2021' provides an overview of Vaginal Cancer C...
March 2021
111 pages
Cancer Biopsy Market Size, Share & Trends Analysis Report By Product (Instruments, Kits & Consumables, Services), By Type (Tissue Biopsies, Liquid Biopsies), By Application, By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
This report can be delivered to the clients within 72 Business Hours Cancer Biopsy Market Growth & Trends The global cancer biopsy market size is expected to reach USD 32.63 billion by 2027, accordi...
December 2020
140 pages
Acute Lymphocytic Leukemia - Epidemiology Forecast to 2029
US$ 3,995.00
Acute Lymphocytic Leukemia - Epidemiology Forecast to 2029 SUMMARY Acute lymphocytic leukemia (ALL), also known as acute lymphoblastic leukemia, is a type of rapidly progressing cancer of the blood an...
November 2020
29 pages
Pancreatic Cancer - Epidemiology Forecast to 2029
US$ 3,995.00
Pancreatic Cancer - Epidemiology Forecast to 2029 SUMMARY Pancreatic cancer (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C25) is the...
November 2020
46 pages
Global Oncology Partnering 2015-2020: Deal trends, players and financials
US$ 3,495.00
... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...
November 2020
2600 pages
Global Cancer Immunotherapy Market Analysis & Forecast to 2025: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
US$ 4,900.00
Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that hav...
November 2020
450 pages
Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma, MPNs), By Technology, By End-use, By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
This report can be delivered to the clients within 72 Business Hours Hemato Oncology Testing Market Growth & Trends The global hemato oncology testing market size is expected to reach USD 7.2 billio...
October 2020
142 pages
Global Breast Cancer Therapeutics Market Size study, By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Clinics, e-commerce, Retail Pharmacies), and Regional Forecasts 2020-2027
US$ 3,950.00
Global Breast Cancer Therapeutics Market is valued approximately at USD 19.57 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.16% over the forecast period 2020-20...
October 2020
200 pages
Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2024
US$ 3,000.00
... to launch new and most effective therapies. According to the report “Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application ...
October 2020
195 pages
Global Oncology Companion Diagnostic Market Size study, by Product & Service (Product and Services), by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) and Others), by Disease Type (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Prostate Cancer and Others), by End User (Hospital, Pathology/Diagnostic Laboratory and Academic Medical Center) and Regional Forecasts 2020-2027
US$ 4,950.00
Global Oncology Companion Diagnostic Market is valued approximately at USD 2.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.7% over the forecast period 2020-20...
October 2020
200 pages
Oncology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Cancer Type, By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
This report can be delivered to the clients within 72 Business Hours Oncology Clinical Trials Market Growth & Trends The global oncology clinical trials market size is expected to reach USD 16.6 bil...
September 2020
120 pages
Global Thyroid Cancer Diagnostic Market Size study, by Type (Papillary carcinoma, Follicular carcinoma, Others), by Technique (Blood test, Imaging, Biopsy, Others), by End-Use (Hospital laboratories, Cancer diagnostic centers, Research institutes) and Regional Forecasts 2020-2027
US$ 4,950.00
Global Thyroid Cancer Diagnostic Market is valued approximately at USD 2.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2020-2027. T...
September 2020
200 pages
Oncology Companion Diagnostic Market Size, Share & Trends Analysis Report By Product & Service, By Technology (IHC, NGS), By Disease Type (Breast Cancer, Leukemia), By End-use, By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
This report can be delivered to the clients within 48 Business Hours Oncology Companion Diagnostic Market Growth & Trends The global oncology companion diagnostic market size is expected to reach US...
September 2020
183 pages
Global Cancer Biomarkers Market Size study, by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics-based Tests), by Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-biomarkers), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Others), by Application (Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others) and Regional Forecasts 2020-2027
US$ 4,950.00
Global Cancer Biomarkers Market is valued at approximately at USD 10.9 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.8% over the forecast period 2020-2027. Acco...
August 2020
200 pages
